Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks

• Published in: Systems biology in reproductive medicine 2022-08, Vol.68 (4), p.247-257
• Main Authors: Vogt, Peter H., Besikoglu, Banu, Bettendorf, Markus, Frank-Herrmann, Petra, Zimmer, Jutta, Bender, Urike, Knauer-Fischer, Sabine, Choukair, Daniela, Sinn, Peter, Doerr, Helmuth-Guenther, Woelfle, Joachim, Heidemann, Peter H., Lau, Yun-Fai Chris, Strowitzki, Thomas
• Format: Article
• Language: English
• Subjects: 45X/46XY mosaic DSD; Chromosome Breakage; Chromosomes, Human, Y - metabolism; DEAD-box RNA Helicases - genetics; di-centric Y chromosome; Female; Germ cell tumour risk; Gonadoblastoma - genetics; Gonadoblastoma - metabolism; Gonadoblastoma - pathology; Humans; Male; Minor Histocompatibility Antigens; Neoplasms, Germ Cell and Embryonal; OCT3/4 expression GBY expression; Ovarian Neoplasms - genetics; Phenotype; Sex Chromosome Disorders of Sex Development
• ISSN: 1939-6368; 1939-6376
• DOI: 10.1080/19396368.2022.2057258

"Differences of Sexual Development (DSD)," individuals with rearranged Y chromosome breaks in their 46,XY cells are reported with male and female gender phenotypes and differences in germ cell tumour (GCT) risk. This raised the question of whether male or female gender and GCT risk depends on the site of the break and/or rearrangement of the individual´s Y chromosome. In this paper, we report molecular mapping of the breakpoint on the aberrant Y chromosome of 22 DSD individuals with a 45,X/46,XY karyotype reared with a different gender. Their Y chromosome breaks are found at different sites on the long and short Y arms. Our data indicate that gender rearing is, neither dependent on the site of Y breakage, nor on the amount of 45,X0 cells in the individuals' leukocytes. Most prominent are secondary rearrangements of the Y chromosome breaks forming di-centric Y-structures ("dic-Y"). Duplications of the short Y arm and the proximal part of the long Y arm are the results. A putative GCT risk has been analysed with immunohistochemical experiments on some dysgenetic gonadal tissue sections. With specific antibodies for OCT3/4 expression, we marked the pluripotent germ cell fraction being potential tumour precursor cells. With specific antibodies for DDX3Y, TSPY, and UTY we analyzed their putative Gonadoblastoma Y (GBY) tumour susceptibility function in the same specimen. We conclude GBY expression is only diagnostic for GCT development in the aberrant germ cells of these DSD individuals when strong OCT3/4 expression has marked their pluripotency.